Leonard H. Calabrese

cleveland clinic

H指数:78

被引数:3.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

SARS-CoV-2-specific monoclonal antibody AER002 in Long COVID: an exploratory randomized phase 2a mechanistic trial

长新冠中SARS-CoV-2特异性单克隆抗体AER002：一项探索性随机2a期机制试验

Nature Communications

IF15.7

2026-09-300

OAAI

Michael J. Peluso; Dylan Ryder; Thomas Dalhuisen; Danny Hoi Tsun Chu; Meghann C. Williams; Antonio E. Rodriguez; Brian H. LaFranchi; Joanna Vinden; Emily A. Fehrman; Beatrice Huang; Rebecca Hoh; Kofi A. Asare; Kathleen Bellon Pizarro; Mohammad Sofiqur Rahman; Emilio de Narvaez; Mark M. Painter; E. John Wherry; Zoe N. Swank; Louise L. Hansen; David R. Walt; Yoshinori Fukazawa; Anisha Sekar; Steven E. Bellan; Holly Tieu; Josephat Asiago; Prakash Bhuyan; Rajeev Venkayya; Robert R. Flavell; Henry VanBrocklin; J. Daniel Kelly; Priscilla Y. Hsue; Matthew S. Durstenfeld; Peter W. Hunt; Leonard Calabrese; Ma Somsouk; Jeffrey N. Martin; David V. Glidden; Amelia N. Deitchman; Timothy J. Henrich; Steven G. Deeks

AI in the Exam Room: Its Potential to Transform the Healing Relationship in Rheumatology and Beyond

AI在诊室：其在风湿病学等领域转变医患关系的潜力

Arthritis & Rheumatology

IF10.9

2026-08-290

PRE

Target Trial Emulation of Oral Antivirals for B-Cell-Depleted COVID-19 Patients-Reply to Chen et al

针对B细胞耗竭型COVID-19患者口服抗病毒药物的靶向试验模拟——回复Chen et al

Clinical Infectious Diseases

IF7.3

2026-01-010

PRE

Effectiveness of Nirmatrelvir/Ritonavir or Molnupiravir Use in Immunocompromised Patients on B-Cell-Depleting Therapy With COVID-19: A Target Trial Emulation Study

Nirmatrelvir/Ritonavir或Molnupiravir在免疫抑制患者中用于B细胞耗竭治疗合并COVID-19的疗效：一项目标试验模拟研究

CLINICAL INFECTIOUS DISEASES

IF7.3

2025-10-010

PRE

Long COVID for the Rheumatologist

长新冠对风湿病医师的意义

infectious disease clinics of north america

IF2.9

2025-02-010

PRE

SARS-CoV-2 ORF8 drives osteoclastogenesis in preexisting immune-mediated diseases

JCI INSIGHT

IF6.1

2024-12-201

Preventing herpes zoster in immunocompromised patients: Current concepts

CLEVELAND CLINIC JOURNAL OF MEDICINE

IF4.1

2024-07-011

Cytomegalovirus Infection Facilitates the Costimulation of CD57+CD28-CD8 T Cells in HIV Infection and Atherosclerosis via the CD2-LFA-3 Axis

JOURNAL OF IMMUNOLOGY

IF3.4

2023-12-044

PRE

Long COVID in inflammatory rheumatic diseases-what's in a name?

LANCET RHEUMATOLOGY

IF16.4

2023-07-011

OAAI

Interleukin 6 Blockade With Tocilizumab Diminishes Indices of Inflammation That Are Linked to Mortality in Treated Human Immunodeficiency Virus Infection

CLINICAL INFECTIOUS DISEASES

IF7.3

2023-04-0312

2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases

ARTHRITIS CARE & RESEARCH

IF3.3

2023-01-0480

Bass, Anne R.; Chakravarty, Eliza; Akl, Elie A.; Bingham, Clifton O.; Calabrese, Leonard; Cappelli, Laura C.; Johnson, Sindhu R.; Imundo, Lisa F.; Winthrop, Kevin L.; Arasaratnam, Reuben J.; Baden, Lindsey R.; Berard, Roberta; Bridges, S. Louis, Jr.; Cheah, Jonathan T. L.; Curtis, Jeffrey R.; Ferguson, Polly J.; Hakkarinen, Ida; Onel, Karen B.; Schultz, Grayson; Sivaraman, Vidya; Smith, Benjamin J.; Sparks, Jeffrey A.; Vogel, Tiphanie P.; Williams, Eleanor Anderson; Calabrese, Cassandra; Cunha, Joanne S.; Fontanarosa, Joann; Gillispie-Taylor, Miriah C.; Gkrouzman, Elena; Iyer, Priyanka; Lakin, Kimberly S.; Legge, Alexandra; Lo, Mindy S.; Lockwood, Megan M.; Sadun, Rebecca E.; Singh, Namrata; Sullivan, Nancy; Tam, Herman; Turgunbaev, Marat; Turner, Amy S.; Reston, James

2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases

ARTHRITIS & RHEUMATOLOGY

IF10.9

2023-01-0424